Literature DB >> 9010205

Assembly of CNS myelin in the absence of proteolipid protein.

M Klugmann1, M H Schwab, A Pühlhofer, A Schneider, F Zimmermann, I R Griffiths, K A Nave.   

Abstract

Two proteolipid proteins, PLP and DM20, are the major membrane components of central nervous system (CNS) myelin. Mutations of the X-linked PLP/DM20 gene cause dysmyelination in mouse and man and result in significant mortality. Here we show that mutant mice that lack expression of a targeted PLP gene fail to exhibit the known dysmyelinated phenotype. Unable to encode PLP/DM20 or PLP-related polypeptides, oligodendrocytes are still competent to myelinate CNS axons of all calibers and to assemble compacted myelin sheaths. Ultrastructurally, however, the electron-dense 'intraperiod' lines in myelin remain condensed, correlating with its reduced physical stability. This suggests that after myelin compaction, PLP forms a stabilizing membrane junction, similar to a "zipper." Dysmyelination and oligodendrocyte death emerge as an epiphenomenon of other PLP mutations and have been uncoupled in the PLP null allele from the risk of premature myelin breakdown.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9010205     DOI: 10.1016/s0896-6273(01)80046-5

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  127 in total

1.  Quantitative assessment of neurologic deficits in a chronic progressive murine model of CNS demyelination.

Authors:  D B McGavern; L Zoecklein; K M Drescher; M Rodriguez
Journal:  Exp Neurol       Date:  1999-07       Impact factor: 5.330

2.  Axonal loss results in spinal cord atrophy, electrophysiological abnormalities and neurological deficits following demyelination in a chronic inflammatory model of multiple sclerosis.

Authors:  D B McGavern; P D Murray; C Rivera-Quiñones; J D Schmelzer; P A Low; M Rodriguez
Journal:  Brain       Date:  2000-03       Impact factor: 13.501

Review 3.  The unfolded protein response in protein aggregating diseases.

Authors:  Alexander Gow; Ramaswamy Sharma
Journal:  Neuromolecular Med       Date:  2003       Impact factor: 3.843

4.  Myelin proteolipid protein-induced aggregation of lipid vesicles: efficacy of the various molecular species.

Authors:  Oscar A Bizzozero; Tamara A Howard
Journal:  Neurochem Res       Date:  2002-11       Impact factor: 3.996

Review 5.  Myelination and support of axonal integrity by glia.

Authors:  Klaus-Armin Nave
Journal:  Nature       Date:  2010-11-11       Impact factor: 49.962

Review 6.  Mechanisms of neuronal dysfunction and degeneration in multiple sclerosis.

Authors:  Ranjan Dutta; Bruce D Trapp
Journal:  Prog Neurobiol       Date:  2010-10-12       Impact factor: 11.685

7.  Progesterone antagonist therapy in a Pelizaeus-Merzbacher mouse model.

Authors:  Thomas Prukop; Dirk B Epplen; Tobias Nientiedt; Sven P Wichert; Robert Fledrich; Ruth M Stassart; Moritz J Rossner; Julia M Edgar; Hauke B Werner; Klaus-Armin Nave; Michael W Sereda
Journal:  Am J Hum Genet       Date:  2014-03-27       Impact factor: 11.025

8.  Genetic background influences UPR but not PLP processing in the rumpshaker model of PMD/SPG2.

Authors:  M McLaughlin; S A Karim; P Montague; J A Barrie; D Kirkham; I R Griffiths; J M Edgar
Journal:  Neurochem Res       Date:  2006-08-31       Impact factor: 3.996

9.  Insertion of mutant proteolipid protein results in missorting of myelin proteins.

Authors:  Catherine Vaurs-Barriere; Kondi Wong; Thais D Weibel; Mones Abu-Asab; Michael D Weiss; Christine R Kaneski; Tong-Hui Mixon; Simona Bonavita; Isabelle Creveaux; John D Heiss; Maria Tsokos; Ehud Goldin; Richard H Quarles; Odile Boespflug-Tanguy; Raphael Schiffmann
Journal:  Ann Neurol       Date:  2003-12       Impact factor: 10.422

Review 10.  Alzheimer's disease as homeostatic responses to age-related myelin breakdown.

Authors:  George Bartzokis
Journal:  Neurobiol Aging       Date:  2009-09-22       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.